BVS Similar Chart Price Prediction
The price of BVS is predicted to go up -8.57%, based on the high correlation periods with BJDX. The similarity of these two price pattern on the periods is 91.38%.
BVS
BJDX
Down: -8.57%Similarity: 91.38%
BVS Revenue Forecast
BVS EPS Forecast
BVS FAQs
What is BVS revenue forecast for next quarter？
What is BVS eps forecast for next quarter？
BVS Analyst's Forecast
Robbie Marcus
JP Morgan
Sell → Hold
2024-12-17
Price Target
$12 → $13
Upside
+16.54%
JPMorgan upgraded Bioventus to Neutral from Underweight with a price target of $13, up from $12. The firm cites better visibility into the company's growth and several quarters of improved execution for the upgrade. 2024 marked a return to stability for Bioventus, with hyaluronic acid headwinds now lapped and "fully in the rearview and pockets of strength in areas like Ultrasonics," the analyst tells investors in a research note. As such, JPMorgan feels incrementally more positive about Bioventus into 2025.
William Plovanic
Canaccord Genuity
Strong Buy
2024-11-06
Price Target
$12 → $15
Upside
+33.1%
Alexander Nowak
Craig-Hallum
Strong Buy
2024-09-27
Price Target
$12 → $17
Upside
+40.15%
